Skip to search formSkip to main contentSkip to account menu

Angiogenesis Inhibitors

Known as: Neovascularization inhibitors, Angiostatic Agents, Agents, Anti-Angiogenetic 
An agent or endogenous substance that inhibits the formation of capillaries from existing blood vessels. In cancer therapy, angiogenesis inhibitors… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
BACKGROUND Nivolumab, a programmed death 1 (PD-1) checkpoint inhibitor, was associated with encouraging overall survival in… 
Review
2007
Review
2007
Curcumin, a polyphenolic compound derived from dietary spice turmeric, possesses diverse pharmacologic effects including anti… 
Review
2005
Review
2005
Inhibiting angiogenesis is a promising strategy for treatment of cancer and several other disorders, including age-related… 
Review
2005
Review
2005
  • R. Jain
  • Science
  • 2005
  • Corpus ID: 46664074
Solid tumors require blood vessels for growth, and many new cancer therapies are directed against the tumor vasculature. The… 
Review
2002
Review
2002
Angiogenesis inhibitors are a new class of drugs, for which the general rules involving conventional chemotherapy might not apply… 
Highly Cited
1999
Highly Cited
1999
Solid tumors depend on angiogenesis for their growth. In a transgenic mouse model of pancreatic islet cell carcinogenesis (RIP1… 
Highly Cited
1997
Highly Cited
1994
Highly Cited
1994
Thalidomide is a potent teratogen causing dysmelia (stunted limb growth) in humans. We have demonstrated that orally administered… 
Highly Cited
1990
Highly Cited
1990
  • J. Folkman
  • Journal of the National Cancer Institute
  • 1990
  • Corpus ID: 15189114
Method of treating a wound or burn which comprises directly dressing its surface with non-woven fabric comprising staple fibers…